Healthleap, a startup developing an AI platform that analyzes patient records to identify individuals at risk of undiagnosed illnesses, has secured $38 million in seed and Series A funding. The company aims to expand its reach in the healthcare sector by leveraging natural language processing to uncover clinical signs often missed in standard electronic health record reviews.
What Happened
The financing consists of an $8 million seed round co-led by Sequoia Capital and First Round Capital, followed by a $30 million Series A led by Hummingbird Ventures. The company did not disclose its valuation. Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, Healthleap initially offered a clinical nutrition tool before pivoting to a broader platform that identifies patients admitted to hospitals who may be suffering from conditions such as malnutrition or delirium. According to CEO and co-founder Josiah Meyer, the platform plugs into hospital electronic health record systems and uses language models to extract affirmative or negated mentions of clinical concepts from clinicians’ written notes, such as references to poor appetite, recent weight loss, or trouble swallowing. This qualitative data is combined with structured information like lab reports and vital signs to generate risk scores, which are then integrated into care teams’ existing workflows via a dashboard. The company emphasizes that its software does not diagnose patients but rather highlights items for additional review.
Why It Matters
The funding round highlights growing investor interest in AI applications that address clinical blind spots in hospital settings. Malnutrition is a significant but often overlooked issue, with research suggesting that 20% to 50% of hospital inpatients are malnourished, a condition linked to longer stays, impaired wound healing, and higher mortality rates. Healthleap reports that its platform is currently deployed in more than 50 hospitals, including major systems like Penn Medicine, Cedars-Sinai, and Emory Healthcare. The startup claims significant financial impact for its partners, citing $23.8 million in annualized financial impact at the Hospital of the University of Pennsylvania, driven by additional reimbursement and shorter hospital stays. Josiah Meyer stated that every customer has seen a 5x hard ROI or more, with some cases exceeding 20x annual total ROI. The company sells three-year contracts priced according to a hospital’s licensed bed count, utilizing an outcome-based pricing model validated by hospital finance teams.
The Bottom Line
Healthleap plans to use the new capital to invest in engineering, product development, sales, and customer success. The company aims to expand its platform to support the identification of more than 40 major health conditions and plans to move into outpatient and home care markets in the future.